Cyclophosphamide therapy in pediatric multiple sclerosis

Abstract

Cyclophosphamide is an option for the treatment of children with aggressive multiple sclerosis refractory to first-line therapies. Recommendations regarding patient selection, treatment administration, and monitoring are discussed.